SIGNATURE FORMULATIONS, LLC – Trademark Portfolio
Entity Type: 16
SIGNATURE FORMULATIONS, LLC holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 8 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include ELIXIR 11 and FORMULAS FOR YOU. The owner is based in Columbus, OH.
5151 REED ROAD, SUITE 250 B
Columbus, OH 43220
Showing of trademarks Trademarks
Trademark Classifications
SIGNATURE FORMULATIONS, LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does SIGNATURE FORMULATIONS, LLC have?
SIGNATURE FORMULATIONS, LLC has 8 U.S. trademarks filed with the USPTO. Of these, 2 registered, 5 abandoned, 1 cancelled.
What trademark classes does SIGNATURE FORMULATIONS, LLC file in?
SIGNATURE FORMULATIONS, LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.
What are SIGNATURE FORMULATIONS, LLC's most well-known trademarks?
SIGNATURE FORMULATIONS, LLC's registered trademark portfolio includes well-known marks such as ELIXIR 11 and FORMULAS FOR YOU. These are among 2 currently registered trademarks in the portfolio.
What is SIGNATURE FORMULATIONS, LLC's trademark registration success rate?
SIGNATURE FORMULATIONS, LLC has a 25% trademark registration rate, with 2 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.